PVI
IDYA icon

Pura Vida Investments’s IDEAYA Biosciences IDYA Stock Holding History

Pura Vida Investments’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-60,744
Closed -$1.43M – 247
2021
Q1 		$1.43M Buy
+60,744
New +$1.17M 0.04% 179

Other funds holding IDYA

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

Pura Vida Investments's IDYA Position: Q2 2021 in Review

Pura Vida Investments sold out of IDEAYA Biosciences (IDYA) in Q2 2021, closing a stake of 60,744 shares — an estimated $1.43M sold.

Pura Vida Investments first reported a position in IDYA in Q1 2021 and held it in 1 quarter. The position peaked at $1.43M in Q1 2021. 84 funds tracked by Wall St. Rank hold IDYA as of Q2 2021.

  • Pura Vida Investments reported no remaining IDEAYA Biosciences position as of Q2 2021 after selling out during the quarter.
  • Pura Vida Investments sold 60,744 IDEAYA Biosciences shares in Q2 2021, an estimated $1.43M.
  • Pura Vida Investments first reported a position in IDEAYA Biosciences in Q1 2021 and held it in 1 quarter.
  • Pura Vida Investments's IDEAYA Biosciences position peaked at $1.43M in Q1 2021.
  • 84 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2021.

Based on Pura Vida Investments's 13F filing for Q2 2021, filed 16 Aug 2021.